Home / Latest Reports / Herpes Disease Market

Herpes Disease Market By Drug Type (Famciclovir, Acyclovir, Valacyclovir and Other) and End User (Drug Stores, Hospital Pharmacies, Online Pharmacies and Retail Pharmacies) - Global Industry Analysis And Forecast To 2027

Published On : August 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC081222

Request Sample Inquiry Before Buying Request for Customization Check Discount

Industry Outlook

Herpes Disease is an infectious disease caused by herpes simplex virus, also called HSV. Herpes may appear on the genitals or mouth. There are two types of herpes simplex virus (HSV), namely HSV-1 (known as oral herpes, which causes cold sores and fever blisters around the mouth.) and HSV-2 (which is the reason for genital herpes outbreak.). Any person can be affected by herpes; age doesn’t matter as the risk of getting infected is due to exposure.  Symptoms of herpes are blisters sores (mouth or genitals), pain during urination, itching; other symptoms are similar to flu like, fever, headaches, tiredness, lack of appetite, etc. Diagnosis of Herpes Disease can be by physical examination or by HSV test (blood tests). There is no such cure for Herpes disease but by taking safety measures it can be avoided and prevented from spreading. Therefore, the Herpes Disease Market is anticipated to expand and has tremendous scope during the forecast period. The global Herpes Disease Market is anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Herpes Disease Market is based on segment, by Drug Type the market is segmented into Famciclovir, Acyclovir, Valacyclovir and Other, and by End User the market is segmented into Drug Stores, Hospital Pharmacies, Online Pharmacies and Retail Pharmacies.

  • Herpes Disease Market, By Drug Type
  • Famciclovir
  • Acyclovir
  • Valacyclovir
  • Other
  • Herpes Disease Market, By End User
  • Drug Stores 
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Regional Insights

On a global front, the Herpes Disease Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). Global Herpes Disease Market is led by North American region.

Herpes Disease Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Dr. Reddy’s Laboratories Ltd., Novopharm Ltd., GlaxoSmithKline, Apotheca Inc., Hospira Inc., Novartis AG, Teva Pharmaceuticals Inc., Sandoz Inc., Gilead, Merck, Abbott, Mylan, Vical and Mylan Pharmaceuticals Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Dr. Reddy’s Laboratories Ltd.
  • Novopharm Ltd.
  • GlaxoSmithKline
  • Apotheca Inc.
  • Hospira Inc.
  • Novartis AG
  • Teva Pharmaceuticals Inc.
  • Sandoz Inc.
  • Gilead
  • Merck
  • Abbott
  • Mylan
  • Vical
  • Mylan Pharmaceuticals Inc.

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Herpes Disease Market, By Drug Type, Estimates and Forecast, 2017-2027 ($Million)

o   Famciclovir

o   Acyclovir

o   Valacyclovir

o   Other

o   Herpes Disease Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o   Drug Stores 

o   Hospital Pharmacies

o   Online Pharmacies

o   Retail Pharmacies

Herpes Disease Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Herpes Disease Market, By Country

o   U.S. Herpes Disease Market

o   Canada Herpes Disease Market

o   Mexico Herpes Disease Market

o   Europe

§  Europe Herpes Disease Market, By Country

o   Germany Herpes Disease Market

o   UK Herpes Disease Market

o   France Herpes Disease Market

o   Russia Herpes Disease Market

o   Italy Herpes Disease Market

o   Rest of Europe Herpes Disease Market

o   Asia-Pacific

§  Asia-Pacific Herpes Disease Market, By Country

o   China Herpes Disease Market

o   Japan Herpes Disease Market

o   South Korea  Herpes Disease Market

o   India Herpes Disease Market

o   Southeast Asia Herpes Disease Market

o   Rest of Asia-Pacific Herpes Disease Market

o   South America

§  South America Herpes Disease Market, By Country

o   Brazil Herpes Disease Market

o   Argentina Herpes Disease Market

o   Columbia Herpes Disease Market

o   Rest of South America Herpes Disease Market

o   Middle East and Africa

§  Middle East and Africa Herpes Disease Market, By Country

o   Saudi Arabia Herpes Disease Market

o   UAE Herpes Disease Market

o   Egypt Herpes Disease Market

o   Nigeria Herpes Disease Market

o   South Africa Herpes Disease Market

o   Rest of MEA Herpes Disease Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       Herpes Disease Market, By Drug Type

5.1.     Introduction

5.2.     Global Herpes Disease Revenue and Market Share by Drug Type (2017-2027)

5.2.1.  Global Herpes Disease Revenue and Revenue Share by Drug Type (2017-2027)

5.3.     Famciclovir

5.3.1.  Global Famciclovir  Revenue and Growth Rate (2017-2027)

5.4.     Acyclovir

5.4.1.  Global Acyclovir Revenue and Growth Rate (2017-2027)

5.5.     Valacyclovir

5.5.1.  Global Valacyclovir Revenue and Growth Rate (2017-2027)

5.6.     Other

5.6.1.  Global Other  Revenue and Growth Rate (2017-2027)

6.       Herpes Disease Market, By End User

6.1.     Introduction

6.2.     Global Herpes Disease Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Herpes Disease Revenue and Revenue Share by End User (2017-2027)

6.3.     Drug Stores 

6.3.1.  Global Drug Stores   Revenue and Growth Rate (2017-2027)

6.4.     Hospital Pharmacies

6.4.1.  Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)

6.5.     Online Pharmacies

6.5.1.  Global Online Pharmacies Revenue and Growth Rate (2017-2027)

6.6.     Retail Pharmacies

6.6.1.  Global Retail Pharmacies Revenue and Growth Rate (2017-2027)

7.       Herpes Disease Market, By Region

7.1.     Introduction

7.2.     Global Herpes Disease Revenue and Market Share by Regions

7.2.1.  Global Herpes Disease Revenue by Regions (2017-2027)

7.3.     North America Herpes Disease by Countries

7.3.1.  North America Herpes Disease Revenue and Growth Rate (2017-2027)

7.3.2.  North America Herpes Disease Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Herpes Disease by Countries

7.4.1.  Europe Herpes Disease Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Herpes Disease Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Herpes Disease by Countries

7.5.1.  Asia-Pacific Herpes Disease Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Herpes Disease Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Herpes Disease by Countries

7.6.1.  South America Herpes Disease Revenue and Growth Rate (2017-2027)

7.6.2.  South America Herpes Disease Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Herpes Disease by Countries

7.7.1.  Middle East and Africa Herpes Disease Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Herpes Disease Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     Dr. Reddy’s Laboratories Ltd.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     Novopharm Ltd.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     GlaxoSmithKline

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Apotheca Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Hospira Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Novartis AG

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     Teva Pharmaceuticals Inc.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Sandoz Inc.

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     Gilead

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

8.10. Merck

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.       Revenue and Market Share

8.11. Abbott

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.       Revenue and Market Share

8.12. Mylan

8.12.1.      Business Overview

8.12.2.       Service Portfolio

8.12.3.      Strategic Developments

8.12.4.       Revenue and Market Share

8.13. Vical

8.13.1.      Business Overview

8.13.2.       Service Portfolio

8.13.3.      Strategic Developments

8.13.4.       Revenue and Market Share

8.14. Mylan Pharmaceuticals Inc.

8.14.1.      Business Overview

8.14.2.       Service Portfolio

8.14.3.      Strategic Developments

8.14.4.       Revenue and Market Share

9.       Global Herpes Disease Market Competition, by Manufacturer

9.1.     Global Herpes Disease Revenue and Market Share by Manufacturer (2017-2017)

9.2.     Global Herpes Disease Price By Region (2017-2017)

9.3.     Top 5 Herpes Disease Manufacturer Market Share

9.4.     Market Competition Trend

10.    Herpes Disease Market Forecast (2017-2027)

10.1. Global Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Herpes Disease Market Forecast by Regions (2017-2027)

10.2.1.      North America Herpes Disease Market Forecast (2017-2027)

10.2.1.1. United States Herpes Disease Market Forecast (2017-2027)

10.2.1.2. Canada Herpes Disease Market Forecast (2017-2027)

10.2.1.3. Mexico Herpes Disease Market Forecast (2017-2027)

10.2.2.      Europe Herpes Disease Market Forecast (2017-2027)

10.2.2.1. Germany Herpes Disease Market Forecast (2017-2027)

10.2.2.2. France Herpes Disease Market Forecast (2017-2027)

10.2.2.3. UK Herpes Disease Market Forecast (2017-2027)

10.2.2.4. Russia Herpes Disease Market Forecast (2017-2027)

10.2.2.5. Italy Herpes Disease Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Herpes Disease Market Forecast (2017-2027)

10.2.3.      Asia-Pacific Herpes Disease Market Forecast (2017-2027)

10.2.3.1. China Herpes Disease Market Forecast (2017-2027)

10.2.3.2. Japan Herpes Disease Market Forecast (2017-2027)

10.2.3.3. Korea Herpes Disease Market Forecast (2017-2027)

10.2.3.4. India Herpes Disease Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Herpes Disease Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Herpes Disease Market Forecast (2017-2027)

10.2.4.      South America Herpes Disease Market Forecast (2017-2027)

10.2.4.1. Brazil Herpes Disease Market Forecast (2017-2027)

10.2.4.2. Argentina Herpes Disease Market Forecast (2017-2027)

10.2.4.3. Columbia Herpes Disease Market Forecast (2017-2027)

10.2.4.4. Rest of South America Herpes Disease Market Forecast (2017-2027)

10.2.5.      Middle East and Africa Herpes Disease Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Herpes Disease Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Herpes Disease Market Forecast (2017-2027)

10.2.5.3. Egypt Herpes Disease Market Forecast (2017-2027)

10.2.5.4. Nigeria Herpes Disease Market Forecast (2017-2027)

10.2.5.5. South Africa Herpes Disease Market Forecast (2017-2027)

10.2.5.6. Turkey Herpes Disease Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Herpes Disease Market Forecast (2017-2027)

10.3. Herpes Disease Market Forecast by Drug Type (2017-2027)

10.3.1.      Herpes Disease Forecast by Drug Type (2017-2027)

10.3.2.      Herpes Disease Market Share Forecast by Drug Type (2017-2027)

10.4. Herpes Disease Market Forecast by End User (2017-2027)

10.4.1.      Herpes Disease Forecast by End User (2017-2027)

10.4.2.      Herpes Disease Market Share Forecast by End User (2017-2027)

List of Tables

11. List of Tables and Figures
Figure United States Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Herpes Disease Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Herpes Disease Revenue and Revenue Share by Drug Type (2017-2018)
Figure Global Famciclovir Revenue and Growth Rate (2017-2018)
Figure Global Acyclovir Revenue and Growth Rate (2017-2018)
Figure Global Valacyclovir Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Herpes Disease Revenue and Revenue Share by End User (2017-2018)
Figure Global Drug Stores Revenue and Growth Rate (2017-2018)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Online Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Table Global Herpes Disease Revenue by Regions (2017-2018)
Figure North America Herpes Disease Growth Rate (2017-2018)
Figure North America Herpes Disease Revenue and Growth Rate (2017-2018)
Figure North America Herpes Disease by Countries (2017-2018)
Figure North America Herpes Disease Revenue (Million USD) by Countries (2017-2018)
Figure United States Herpes Disease Growth Rate (2017-2018)
Figure United States Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Herpes Disease Growth Rate (2017-2018)
Figure Canada Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Herpes Disease Growth Rate (2017-2018)
Figure Mexico Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Herpes Disease Growth Rate (2017-2018)
Figure Europe Herpes Disease Revenue and Growth Rate (2017-2018)
Figure Europe Herpes Disease by Countries (2017-2018)
Figure Europe Herpes Disease Revenue (Million USD) by Countries (2017-2018)
Figure Germany Herpes Disease Growth Rate (2017-2018)
Figure Germany Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Herpes Disease Growth Rate (2017-2018)
Figure France Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Herpes Disease Growth Rate (2017-2018)
Figure UK Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Herpes Disease Growth Rate (2017-2018)
Figure Russia Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Herpes Disease Growth Rate (2017-2018)
Figure Italy Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Herpes Disease Growth Rate (2017-2018)
Figure Rest of Europe Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Herpes Disease Growth Rate (2017-2018)
Figure Asia-Pacific Herpes Disease Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Herpes Disease by Countries (2017-2018)
Figure Asia-Pacific Herpes Disease Revenue (Million USD) by Countries (2017-2018)
Figure China Herpes Disease Growth Rate (2017-2018)
Figure China Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Herpes Disease Growth Rate (2017-2018)
Figure Japan Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Herpes Disease Growth Rate (2017-2018)
Figure Korea Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Herpes Disease Growth Rate (2017-2018)
Figure India Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Herpes Disease Growth Rate (2017-2018)
Figure Southeast Asia Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Herpes Disease Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Herpes Disease Growth Rate (2017-2018)
Figure South America Herpes Disease Revenue and Growth Rate (2017-2018)
Figure South America Herpes Disease by Countries (2017-2018)
Figure South America Herpes Disease Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Herpes Disease Growth Rate (2017-2018)
Figure Brazil Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Herpes Disease Growth Rate (2017-2018)
Figure Argentina Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Herpes Disease Growth Rate (2017-2018)
Figure Columbia Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Herpes Disease Growth Rate (2017-2018)
Figure Rest of South America Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Herpes Disease Growth Rate (2017-2018)
Figure Middle East and Africa Herpes Disease Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Herpes Disease by Countries (2017-2018)
Figure Middle East and Africa Herpes Disease Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Herpes Disease Growth Rate (2017-2018)
Figure Saudi Arabia Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Herpes Disease Growth Rate (2017-2018)
Figure United Arab Emirates Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Herpes Disease Growth Rate (2017-2018)
Figure Egypt Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Herpes Disease Growth Rate (2017-2018)
Figure Nigeria Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Herpes Disease Growth Rate (2017-2018)
Figure South Africa Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Herpes Disease Growth Rate (2017-2018)
Figure Turkey Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Herpes Disease Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Herpes Disease Revenue (Millions USD) and Growth Rate (2017-2018)
Table Dr. Reddy’s Laboratories Ltd. Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novopharm Ltd. Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Apotheca Inc. Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Hospira Inc. Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis AG Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Teva Pharmaceuticals Inc. Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sandoz Inc. Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Gilead Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mylan Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Vical Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mylan Pharmaceuticals Inc. Herpes Disease Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Herpes Disease Market Share by Manufacturer
Figure Global Herpes Disease Revenue and Market Share by Manufacturer
Table Global Herpes Disease Price by Region (2017-2017)
Figure Top 5 Herpes Disease Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Herpes Disease Revenue (Millions USD) and Growth Rate (2018-2025)
Table Herpes Disease Market Forecast by Regions (2018-2025)
Figure North America Herpes Disease Market Forecast (2018-2025)
Figure United States Herpes Disease Market Forecast (2018-2025)
Figure Canada Herpes Disease Market Forecast (2018-2025)
Figure Mexico Herpes Disease Market Forecast (2018-2025)
Figure Europe Herpes Disease Market Forecast (2018-2025)
Figure Germany Herpes Disease Market Forecast (2018-2025)
Figure France Herpes Disease Market Forecast (2018-2025)
Figure UK Herpes Disease Market Forecast (2018-2025)
Figure Russia Herpes Disease Market Forecast (2018-2025)
Figure Italy Herpes Disease Market Forecast (2018-2025)
Figure Rest of Europe Herpes Disease Market Forecast (2018-2025)
Figure Asia-Pacific Herpes Disease Market Forecast (2018-2025)
Figure China Herpes Disease Market Forecast (2018-2025)
Figure Japan Herpes Disease Market Forecast (2018-2025)
Figure Korea Herpes Disease Market Forecast (2018-2025)
Figure India Herpes Disease Market Forecast (2018-2025)
Figure Southeast Asia Herpes Disease Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Herpes Disease Market Forecast (2018-2025)
Figure South America Herpes Disease Market Forecast (2018-2025)
Figure Brazil Herpes Disease Market Forecast (2018-2025)
Figure Argentina Herpes Disease Market Forecast (2018-2025)
Figure Columbia Herpes Disease Market Forecast (2018-2025)
Figure Rest of South America Herpes Disease Market Forecast (2018-2025)
Figure Middle East and Africa Herpes Disease Market Forecast (2018-2025)
Figure Saudi Arabia Herpes Disease Market Forecast (2018-2025)
Figure United Arab Emirates Herpes Disease Market Forecast (2018-2025)
Figure Egypt Herpes Disease Market Forecast (2018-2025)
Figure Nigeria Herpes Disease Market Forecast (2018-2025)
Figure South Africa Herpes Disease Market Forecast (2018-2025)
Figure Turkey Herpes Disease Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Herpes Disease Market Forecast (2018-2025)
Figure Global Herpes Disease Forecast by Drug Type (2018-2025)
Figure Global Herpes Disease Market Share Forecast by Drug Type (2018-2025)
Figure Global Herpes Disease Forecast by Drug Type (2018-2025)
Figure Global Herpes Disease Forecast by End User (2018-2025)
Figure Global Herpes Disease Market Share Forecast by End User (2018-2025)
Figure Global Herpes Disease Forecast by End User (2018-2025)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*